Watch Ticker

Ionis Pharmaceuticals, Inc. Common Stock

Go to Ionis Pharmaceuticals, Inc. Common Stock Website

$43.45

0.42 (0.98%)

Live

Previous Close

$43.03

Day Range

$42.26 - $43.74

Previous Day Range

$42.28 - $43.4

Market Cap

$6.9 billion USD

Day Vol.

2.3 million

Previous Day Vol.

2.3 million

Currency

USD

Primary Exchange

Nasdaq

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Biogen Inc. - Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

Biogen will present scientific data on lecanemab and tau-targeted therapies at the 2025 Alzheimer's Association International Conference, showcasing long-term clinical trial results and potential new treatment approaches for Alzheimer's disease.

Related tickers: BIIB, ESAIY, IONS.

Read Full Article

Delveinsight - Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The angioedema treatment market is expected to grow due to the rising prevalence of allergic conditions and increasing awareness of hereditary angioedema (HAE). The pipeline analysis shows over 15 companies are developing 20+ angioedema drugs, with promising therapies in different clinical trial phases.

Related tickers: IONS, ATXS, NTLA, KALV, CAMP.

Read Full Article

Trending Tickers

Please sign in to view